Safety and Efficacy of the HighLife Transcatherter Mitral Valve Replacement System in Patients With Moderate-severe or Severe Mitral Regurgitation in China

NCT05610566 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Mitral Regurgitation

Interventions

DEVICE: the HighLife Trans-Septal Transcatheter Mitral Valve Replacement System

Sponsor

Peijia Medical Technology (Suzhou) Co., Ltd.

Collaborators

[object Object]
[object Object]
[object Object]